Results 211 to 220 of about 635,953 (258)

Single-component self-assembling protein nanoparticles displaying stabilized prefusion-closed hemagglutinin trimers for influenza vaccine development. [PDF]

Nat Commun
Zhang YN, Zhu X, Braz Gomes K, Lee YZ, DesRoberts C, He L, Wilson IA, Zhu J.   +7 more
europepmc   +1 more source

Unmasking the Influence of Viral Micro‐RNAs on Host Immunity

Immunology &Cell Biology, EarlyView.
Viral micro‐RNAs are increasingly recognized as key modulators of host–virus interactions. They influence multiple immune functions, including antigen presentation, T‐cell activation, and cytokine signaling, while also tuning viral gene expression to promote persistence.
Riley J. K. Easton, Bernadette M. Saunders   +1 more
wiley   +1 more source

Influenza vaccine hesitancy versus uptake in seven Chinese megacities: a cross-sectional survey. [PDF]

Infect Dis Poverty
Li T, Xiong Q, Wu P.
europepmc   +1 more source

Would patients over 65 years of age accept vaccination while hospitalised? An assessment of eligibility and acceptability

Internal Medicine Journal, EarlyView.
Abstract Background Vaccination is effective at preventing severe illness related to influenza, pneumococcal disease and coronavirus disease 2019 COVID‐19. Vaccine coverage among older Australians is incomplete, and hospitals currently administer very few vaccine doses.
Victoria Deacon, Kristen Overton, Parthsinh Solanki, Ethan MacMinn, Anthea L. Katelaris, Jeffrey J. Post   +5 more
wiley   +1 more source

Influenza vaccine effectiveness against outpatient acute respiratory illness with laboratory-confirmed influenza, United States, 2024-25 season. [PDF]

Clin Infect Dis
Chung JR, Price AM, House SL, Mills J, Wernli KJ, Sanchez M, Martin ET, Vaughn IA, Murugan V, Kramer J, Saade EA, Faryar K, Gaglani M, Raiyani C, Zimmerman RK, Taylor LH, Williams OL, Walter EB, DaSilva J, Kirby MK, Levine MZ, Kondor R, Noble EK, Sumner KM, Ellington SR, Flannery B, US Flu VE Network Investigators.   +26 more
europepmc   +1 more source

Emerging threat of avian influenza to the world's vultures

Conservation Biology, EarlyView.
Jon Morant, Andrea Santangeli, Pablo Plaza, Sergio A. Lambertucci   +3 more
wiley   +1 more source

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors

Internal Medicine Journal, EarlyView.
Abstract Complement inhibitor therapy carries a risk of serious infections, including meningococcal disease. Here we provide evidence‐based recommendations and expert consensus for immunisation and prophylactic treatment of patients receiving, or planning to receive, complement inhibitors for neurological conditions in the Australian setting.
Katherine A. Buzzard, Michael Barnett, Heidi Beadnall, Mirasol Forcadela, Lesley‐Ann Hall, Victoria G. Hall, Todd Hardy, Danny Hsu, Paul Kinsella, Mastura Monif, Sudarshini Ramanathan, Stephen W. Reddel, Sean Riminton, Douglas F. Johnson   +13 more
wiley   +1 more source

Influenza Vaccine as a Potential Trigger for Urticarial Phase Bullous Pemphigoid: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Madani A, Alraddadi B, Alajlan A, Alkanaan R.   +3 more
europepmc   +1 more source

Tissue Resident Memory Cells: Friend or Foe?

Immunology, EarlyView.
Tissue‐resident memory T cells (TRM cells) are specialised immune cells in barrier tissues like the lungs, skin and gut, providing rapid host defence and tumour surveillance. Their retention and differentiation are regulated by molecules such as CD69, CD103 and TGF‐β. Dysregulation of TRM cells can lead to chronic activation, driving conditions such as
Chidimma F. Chude, Jude E. Uzonna, Janilyn Arsenio   +2 more
wiley   +1 more source

Safety profile of India's influenza vaccine in a large-scale corporate vaccination drive. [PDF]

Hum Vaccin Immunother
Khatuja N, Aggarwal R, Dutta T, Mahajan M.   +3 more
europepmc   +1 more source